Corcept Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Alaunos Therapeutics -1127000 1.11M 2024-09
ANI Pharmaceuticals USD 110.29M 134.46M 2024-12
Ardelyx USD 97.86M 15.35M 2024-12
Aurora Cannabis CAD 9.35M 6.18M 2024-12
BioMarin Pharmaceutical USD 611.17M 53.89M 2024-12
Bristol-Myers Squibb USD 8.18B 947M 2025-03
Canopy Growth CAD 24.1M 2.26M 2024-12
Corcept Therapeutics USD 178.93M 745K 2024-12
Eli Lilly USD 10.5B 624.7M 2025-03
J&J USD 14.6B 816M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Merck USD 12.77B 849M 2025-03
Novartis USD 10.23B 294M 2024-12
Novartis USD 10.24B 313M 2024-12
Pacira USD 147.37M 17.66M 2024-12
Pfizer USD 11.12B 987M 2025-03
Supernus Pharmaceuticals USD 156.96M 1.14M 2024-12
TG Therapeutics USD 92.79M 18.25M 2024-12



Corcept Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.